157 related articles for article (PubMed ID: 35422067)
1. SNORD1C maintains stemness and 5-FU resistance by activation of Wnt signaling pathway in colorectal cancer.
Liu Y; Zhao C; Wang G; Chen J; Ju S; Huang J; Wang X
Cell Death Discov; 2022 Apr; 8(1):200. PubMed ID: 35422067
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of small nucleolar RNA SNORD1C is associated with unfavorable outcome in colorectal cancer.
Liu Y; Zhao C; Sun J; Wang G; Ju S; Qian C; Wang X
Bioengineered; 2021 Dec; 12(1):8943-8952. PubMed ID: 34702132
[TBL] [Abstract][Full Text] [Related]
3. Claudin-7 deficiency promotes stemness properties in colorectal cancer through Sox9-mediated Wnt/β-catenin signalling.
Xu C; Ding YH; Wang K; Hao M; Li H; Ding L
J Transl Med; 2021 Jul; 19(1):311. PubMed ID: 34281572
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of BAP31 Downregulates Galectin-3 to Inhibit the Wnt/β-Catenin Signaling Pathway to Modulate 5-FU Chemosensitivity and Cancer Stemness in Colorectal Cancer.
Liu J; Zhang Q; Wang J; Wang C; Lan T; Wang T; Wang B
Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762705
[TBL] [Abstract][Full Text] [Related]
5. Circ_0082182 promotes oncogenesis and metastasis of colorectal cancer in vitro and in vivo by sponging miR-411 and miR-1205 to activate the Wnt/β-catenin pathway.
Liu R; Deng P; Zhang Y; Wang Y; Peng C
World J Surg Oncol; 2021 Feb; 19(1):51. PubMed ID: 33596920
[TBL] [Abstract][Full Text] [Related]
6. Circ-PRKDC Contributes to 5-Fluorouracil Resistance of Colorectal Cancer Cells by Regulating miR-375/FOXM1 Axis and Wnt/β-Catenin Pathway.
Chen H; Pei L; Xie P; Guo G
Onco Targets Ther; 2020; 13():5939-5953. PubMed ID: 32606803
[TBL] [Abstract][Full Text] [Related]
7. LncRNA SLCO4A1-AS1 facilitates growth and metastasis of colorectal cancer through β-catenin-dependent Wnt pathway.
Yu J; Han Z; Sun Z; Wang Y; Zheng M; Song C
J Exp Clin Cancer Res; 2018 Sep; 37(1):222. PubMed ID: 30201010
[TBL] [Abstract][Full Text] [Related]
8. MiR-30-5p suppresses cell chemoresistance and stemness in colorectal cancer through USP22/Wnt/β-catenin signaling axis.
Jiang S; Miao D; Wang M; Lv J; Wang Y; Tong J
J Cell Mol Med; 2019 Jan; 23(1):630-640. PubMed ID: 30338942
[TBL] [Abstract][Full Text] [Related]
9. Sestrin2 reduces cancer stemness via Wnt/β-catenin signaling in colorectal cancer.
Wei J; Zheng X; Li W; Li X; Fu Z
Cancer Cell Int; 2022 Feb; 22(1):75. PubMed ID: 35148781
[TBL] [Abstract][Full Text] [Related]
10. JARID1B promotes colorectal cancer proliferation and Wnt/β-catenin signaling via decreasing CDX2 level.
Huang D; Xiao F; Hao H; Hua F; Luo Z; Huang Z; Li Q; Chen S; Cheng X; Zhang X; Fang W; Hu X; Liu F
Cell Commun Signal; 2020 Oct; 18(1):169. PubMed ID: 33109187
[TBL] [Abstract][Full Text] [Related]
11. Reduced CD146 expression promotes tumorigenesis and cancer stemness in colorectal cancer through activating Wnt/β-catenin signaling.
Liu D; Du L; Chen D; Ye Z; Duan H; Tu T; Feng J; Yang Y; Chen Q; Yan X
Oncotarget; 2016 Jun; 7(26):40704-40718. PubMed ID: 27302922
[TBL] [Abstract][Full Text] [Related]
12. RUNX1 promotes tumour metastasis by activating the Wnt/β-catenin signalling pathway and EMT in colorectal cancer.
Li Q; Lai Q; He C; Fang Y; Yan Q; Zhang Y; Wang X; Gu C; Wang Y; Ye L; Han L; Lin X; Chen J; Cai J; Li A; Liu S
J Exp Clin Cancer Res; 2019 Aug; 38(1):334. PubMed ID: 31370857
[TBL] [Abstract][Full Text] [Related]
13. RPL17 Promotes Colorectal Cancer Proliferation and Stemness through ERK and NEK2/β-catenin Signaling Pathways.
Ko MJ; Seo YR; Seo D; Park SY; Seo JH; Jeon EH; Kim SW; Park KU; Koo DB; Kim S; Bae JH; Song DK; Cho CH; Kim KS; Lee YH
J Cancer; 2022; 13(8):2570-2583. PubMed ID: 35711835
[No Abstract] [Full Text] [Related]
14. CPT2 downregulation triggers stemness and oxaliplatin resistance in colorectal cancer via activating the ROS/Wnt/β-catenin-induced glycolytic metabolism.
Li H; Chen J; Liu J; Lai Y; Huang S; Zheng L; Fan N
Exp Cell Res; 2021 Dec; 409(1):112892. PubMed ID: 34688609
[TBL] [Abstract][Full Text] [Related]
15. Hsa_circ_0026628 promotes the development of colorectal cancer by targeting SP1 to activate the Wnt/β-catenin pathway.
Zhang X; Yao J; Shi H; Gao B; Zhou H; Zhang Y; Zhao D; Gao S; Wang C; Zhang L
Cell Death Dis; 2021 Aug; 12(9):802. PubMed ID: 34420031
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA HNF1A-AS1 indicates a poor prognosis of colorectal cancer and promotes carcinogenesis via activation of the Wnt/β-catenin signaling pathway.
Zhang X; Xiong Y; Tang F; Bian Y; Chen Y; Zhang F
Biomed Pharmacother; 2017 Dec; 96():877-883. PubMed ID: 29145164
[TBL] [Abstract][Full Text] [Related]
17. FUBP1 promotes colorectal cancer stemness and metastasis via DVL1-mediated activation of Wnt/β-catenin signaling.
Yin H; Gao T; Xie J; Huang Z; Zhang X; Yang F; Qi W; Yang Z; Zhou T; Gao G; Yang X
Mol Oncol; 2021 Dec; 15(12):3490-3512. PubMed ID: 34288405
[TBL] [Abstract][Full Text] [Related]
18. LncRNA HOTAIR is a Prognostic Biomarker for the Proliferation and Chemoresistance of Colorectal Cancer via MiR-203a-3p-Mediated Wnt/ß-Catenin Signaling Pathway.
Xiao Z; Qu Z; Chen Z; Fang Z; Zhou K; Huang Z; Guo X; Zhang Y
Cell Physiol Biochem; 2018; 46(3):1275-1285. PubMed ID: 29680837
[TBL] [Abstract][Full Text] [Related]
19. In Colorectal Cancer Cells With Mutant KRAS, SLC25A22-Mediated Glutaminolysis Reduces DNA Demethylation to Increase WNT Signaling, Stemness, and Drug Resistance.
Wong CC; Xu J; Bian X; Wu JL; Kang W; Qian Y; Li W; Chen H; Gou H; Liu D; Yat Luk ST; Zhou Q; Ji F; Chan LS; Shirasawa S; Sung JJ; Yu J
Gastroenterology; 2020 Dec; 159(6):2163-2180.e6. PubMed ID: 32814111
[TBL] [Abstract][Full Text] [Related]
20. MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating β-catenin signaling in cisplatin-resistant colorectal cancer cells.
Shi L; Xi J; Xu X; Peng B; Zhang B
Biomed Pharmacother; 2019 Jan; 109():902-909. PubMed ID: 30551544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
